待处理
入排:排除
图源:待检查
入排置信度 0.99
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive postremission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, Markus Kratzmann, Lukas Baumann, Olga Eissymont, Martina Crysandt, Martin Görner, Sabine Kayser, Stefan Krause, Christoph Schliemann, Tobias Gaska, Martin Kaufmann, Jens Chemnitz, Markus Schaich, Alexander Hoellein, Uwe Platzbecker, Meinhard Kieser, Carsten Müller-Tidow, Richard F Schlenk
Haematologica 109(6) 1973-1976
入排依据:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板